Mumbai A division bench of the Delhi High Court on Wednesday ordered Dr Reddy's Labs to file its reply to the injunction petition moved by Danish drug maker Novo Nordisk for its blockbuster weight-loss drug semaglutide, which is sold under the brand name Wegovy.
An expert in intellectual property laws told ET that the order may require Dr Reddy's Labs to explain the grounds for exports of weight-loss drug semaglutide.
The court's directive comes on the back of a plea by Novo Nordisk, which alleged patent infringement. The patent for the weight-loss drug is slated to end in March next year.
An expert in intellectual property laws told ET that the order may require Dr Reddy's Labs to explain the grounds for exports of weight-loss drug semaglutide.
The court's directive comes on the back of a plea by Novo Nordisk, which alleged patent infringement. The patent for the weight-loss drug is slated to end in March next year.
You may also like
Coldplay scandal: Kristin Cabot seen for first time after viral video with Andy Byron; watering plants, no wedding ring
Somy Ali says 'I believe her' on Tanushree Dutta's allegations of being harassed at home
Soha Ali Khan enjoys a fun workout session with Fatima Sana Shaikh, says 'next time push-ups pukka'
Who is Andrea Pirlo, the Italian world cup legend appointed head coach of Dubai's United FC?
ED attaches properties for embezzlement of Bhiwani Municipal Council funds
